 |
|
 |
|
  |
|
|
New Elderly vaccines are increasingly needed to offset the growing healthcare needs of aging populations. In both the community and hospital settings,
elderly persons (>65 yrs) are at increased risk of severe disease from infectious pathogens,
an observation now prominent within the 2020 COVID-19 [SARS-CoV-2] pandemic.
MarketVIEW products in the elderly vaccines segment are available for the following areas. Please click on the tablets below:
***Summer 2020*** New 'snap shot' analyses containing a disease profile and a single country revenue forecast can now be ordered across the range.
*For more information about this product and how to order,
e-mail: orders@vaczine-analytics.com
For UK orders VAT will be added at 20%. TERMS and CONDITIONS of purchase will be made available upon enquiry.
| Documents on this page are available in Portable Document Format (PDF) 
|
|
|
|
|
|
